A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia

ClinicalTrials.gov ID: NCT07286032

Public ClinicalTrials.gov record NCT07286032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center, Double-Blind, Phase III Study Evaluating the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia

Study identification

NCT ID: NCT07286032
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.; Industry
Enrollment: 150 participants

Conditions and interventions

Conditions

Patients With Chemotherapy-Induced Thrombocytopenia

Interventions

Hetrombopag Olamine Drug
Hetrombopag Olamine ；Hetrombopag Olamine Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 15, 2026
Primary completion: Nov 30, 2028
Completion: May 31, 2029
Last update posted: Jul 13, 2026

2026 – 2029

United States locations

U.S. sites: 7
U.S. states: 6
U.S. cities: 7

Facility	City	State	ZIP	Site status
Cancer and Blood Specialty Clinic	Los Alamitos	California	90254	Not yet recruiting
AdventHealth Hematology and Oncology Denver Cypress Hematology and Oncology	Denver	Colorado	80210	Not yet recruiting
Oncology & Hematology Associates of West Broward	Coral Springs	Florida	33065	Not yet recruiting
Mid-Florida Hematology & Oncology Centers, P.A.	Orange City	Florida	32763	Recruiting
Springfield Clinic	Springfield	Illinois	62702	Not yet recruiting
Morristown Medical Center	Morristown	New Jersey	07039	Not yet recruiting
New York Cancer and Blood Specialists One Oncology	Shirley	New York	11967	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07286032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 13, 2026 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07286032 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →